Brown & Brown’s fourth quarter was met with a significant negative market reaction, as the company’s revenue fell short of Wall Street expectations despite notably strong year-over-year growth. Management attributed the underperformance to specific factors—including delayed project work, larger-than-anticipated adjustments to incentive commissions, and a tough comparison due to prior-year flood claims processing revenue. CEO J. Powell Brown acknowledged the impact of these issues and the unusual challenge posed by the loss of 275 employees to a competitor, stating, “This is a highly unusual instance...we will defend our rights in court and already have obtained an injunction.”

Is now the time to buy BRO? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Brown & Brown’s Q4 Earnings Call

• Charles Peters (Raymond James) asked about strategies for retaining producers and legal defenses against competitor poaching. CEO J. Powell Brown emphasized the mix of cash and equity compensation and adherence to non-solicitation agreements, stating no major change in retention strategy.
• Jamminder Bhullar (JPMorgan) inquired about the shift of business from E&S to admitted markets. Brown explained this is more prevalent in smaller accounts and cited secular trends favoring E&S, but acknowledged cyclical movement between segments.
• Robert Cox (Goldman Sachs) questioned the moderation in casualty rate increases. Brown described it as a normal market cycle, with CFO Watts clarifying that no structural change is expected and casualty pricing should remain stable.
• Tracy Benguigui (Wolfe Research) sought details on the timing and segment impact of revenue lost to competitor hires. Watts clarified the losses were weighted toward employee benefits and expected to be more visible earlier in the year.
• Michael Zaremski (BMO) asked whether the $23 million revenue loss is expected to grow over time. Brown and Watts clarified that while the current loss is quantified, further impact may depend on future customer and employee decisions, with ongoing monitoring.

Catalysts in Upcoming Quarters

In the upcoming quarters, our analyst team will closely monitor (1) the pace of Accession integration and realization of anticipated synergies, (2) trends in organic growth for both Retail and Specialty Distribution as project delays and market normalization play out, and (3) ongoing impacts of talent departures, particularly on client retention and new business wins. Developing market dynamics and competitive legal outcomes will also be key indicators of execution.

Brown & Brown currently trades at $72, down from $79.62 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it’s free).

Our Favorite Stocks Right Now

If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.

Don’t wait for the next volatility shock. Check out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.